Adachi J, Papaioannou A
Drug Saf. 2001; 24(8):607-24.
PMID: 11480493
DOI: 10.2165/00002018-200124080-00005.
Markham A, Bryson H
Drugs. 1995; 50(2):317-33.
PMID: 8521761
DOI: 10.2165/00003495-199550020-00008.
OConnell S, Tresham J, Fortune C, Farrugia W, McDougall J, SCOGGINS B
Calcif Tissue Int. 1993; 53(2):117-21.
PMID: 8402319
DOI: 10.1007/BF01321889.
Kasperk C, Schneider U, Sommer U, Niethard F, Ziegler R
Calcif Tissue Int. 1995; 57(2):120-6.
PMID: 7584872
DOI: 10.1007/BF00298432.
Pagano G, Lombardi A, FERRARIS G, IMBIMBO B, Perin P
Eur J Clin Pharmacol. 1982; 22(5):469-71.
PMID: 7117360
DOI: 10.1007/BF00542555.
Unanticipated stimulatory action of glucocorticoids on epithelial calcium absorption. Effect of dexamethasone on rat distal colon.
Lee D
J Clin Invest. 1983; 71(2):322-8.
PMID: 6822667
PMC: 436870.
DOI: 10.1172/jci110772.
Bone loss after glucocorticoid therapy.
Lo Cascio V, Bonucci E, IMBIMBO B, Ballanti P, Tartarotti D, Galvanini G
Calcif Tissue Int. 1984; 36(4):435-8.
PMID: 6435841
DOI: 10.1007/BF02405356.
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
Gennari C, IMBIMBO B, Montagnani M, Bernini M, Nardi P, Avioli L
Calcif Tissue Int. 1984; 36(3):245-52.
PMID: 6432287
DOI: 10.1007/BF02405325.
Comparative study of deflazacort, a new synthetic corticosteroid, and dexamethasone on the synthesis of collagen in different rat bone cell populations and rabbit articular chondrocytes.
Guenther H, Felix R, Fleisch H
Calcif Tissue Int. 1984; 36(2):145-52.
PMID: 6430498
DOI: 10.1007/BF02405310.
Corticosteroids and bone.
Peck W, Gennari C, Raisz L, Meunier P, Ritz E, Krane S
Calcif Tissue Int. 1984; 36(1):4-7.
PMID: 6423235
DOI: 10.1007/BF02405286.
25-Hydroxycholecalciferol as an antagonist of adverse corticosteroid effects on phosphate and calcium metabolism in man.
Nuti R, Vattimo A, Turchetti V, Righi G
J Endocrinol Invest. 1984; 7(5):445-8.
PMID: 6239890
DOI: 10.1007/BF03348448.
Effects of prednisone and deflazacort on vertebral bone mass.
Gennari C, IMBIMBO B
Calcif Tissue Int. 1985; 37(6):592-3.
PMID: 3937579
DOI: 10.1007/BF02554912.
In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.
Langhoff E, Olgaard K
Br J Clin Pharmacol. 1986; 21(2):125-9.
PMID: 3485440
PMC: 1400905.
DOI: 10.1111/j.1365-2125.1986.tb05165.x.
Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
BALSAN S, Steru D, Bourdeau A, Grimberg R, Lenoir G
Calcif Tissue Int. 1987; 40(6):303-9.
PMID: 3111667
DOI: 10.1007/BF02556690.
Glucocorticoid-induced osteoporosis.
Ringe J
Clin Rheumatol. 1989; 8 Suppl 2:109-15.
PMID: 2667865
DOI: 10.1007/BF02207244.
Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
Aicardi G, Milani S, IMBIMBO B, Vignolo M, Di Battista E, GUSMANO R
Calcif Tissue Int. 1991; 48(4):283-7.
PMID: 2059880
DOI: 10.1007/BF02556381.
The assessment of the systemic effects of inhaled glucocorticosteroids. The effects of inhaled budesonide vs oral prednisolone on calcium metabolism.
Jennings B, Andersson K, JOHANSSON S
Eur J Clin Pharmacol. 1991; 41(1):11-6.
PMID: 1782971
DOI: 10.1007/BF00280099.
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K, Storm T, van Wowern N, Daugaard H, Egfjord M, Lewin E
Calcif Tissue Int. 1992; 50(6):490-7.
PMID: 1525702
DOI: 10.1007/BF00582160.
Bone turnover during short course prednisolone treatment in patients with chronic obstructive airways disease.
Morrison D, Ali N, Routledge P, Capewell S
Thorax. 1992; 47(6):418-20.
PMID: 1496499
PMC: 463804.
DOI: 10.1136/thx.47.6.418.
